ID: ALA2071026

Max Phase: Preclinical

Molecular Formula: C11H11N3O2

Molecular Weight: 217.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(Cn2cc(C(=O)O)nn2)cc1

Standard InChI:  InChI=1S/C11H11N3O2/c1-8-2-4-9(5-3-8)6-14-7-10(11(15)16)12-13-14/h2-5,7H,6H2,1H3,(H,15,16)

Standard InChI Key:  FGWWLHMRGSFBNQ-UHFFFAOYSA-N

Associated Targets(Human)

Lysine-specific demethylase 4C 1129 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Fe(3+)-Zn(2+) purple acid phosphatase 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 217.23Molecular Weight (Monoisotopic): 217.0851AlogP: 1.33#Rotatable Bonds: 3
Polar Surface Area: 68.01Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.02CX Basic pKa: CX LogP: 2.30CX LogD: -1.17
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.84Np Likeness Score: -1.88

References

1. Leurs U, Clausen RP, Kristensen JL, Lohse B..  (2012)  Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).,  22  (18): [PMID:22917519] [10.1016/j.bmcl.2012.07.091]
2. Hussein WM, Feder D, Schenk G, Schenk G, Guddat LW, McGeary RP..  (2019)  Synthesis and evaluation of novel purple acid phosphatase inhibitors.,  10  (1): [PMID:30774855] [10.1039/C8MD00491A]

Source